-+ 0.00%
-+ 0.00%
-+ 0.00%

SB1 Markets Begins Swedish Orphan Biovitrum Coverage at Buy

MT Newswires·07/29/2026 08:34:57
Listen to the news
08:34 AM EDT, 07/29/2026 (MT Newswires) -- SB1 Markets on Tuesday initiated its coverage of biopharmaceutical company Swedish Orphan Biovitrum (SOBI.ST) with a buy rating and a price target of 515 kronor. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)